相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions
Tanuja Bordia et al.
EXPERIMENTAL NEUROLOGY (2015)
Nicotine Inhibits Microglial Proliferation and Is Neuroprotective in Global Ischemia Rats
Yan-Zhong Guan et al.
MOLECULAR NEUROBIOLOGY (2015)
Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease
R. Lorenz et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
Tessandra Stewart et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice
J. Alex Grizzell et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Visual short-term memory deficits associated with GBA mutation and Parkinson's disease
Nahid Zokaei et al.
BRAIN (2014)
Unravelling mitochondrial pathways to Parkinson's disease
I. Celardo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Angelique Camilleri et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease
Omid Tavassoly et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Gut Feelings About Smoking and Coffee in Parkinson's Disease
Pascal Derkinderen et al.
MOVEMENT DISORDERS (2014)
Predictors of Cognitive Impairment in an Early Stage Parkinson's Disease Cohort
Michele T. M. Hu et al.
MOVEMENT DISORDERS (2014)
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
Danhui Zhang et al.
MOVEMENT DISORDERS (2014)
CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking
Anat Bar-Shira et al.
NEUROBIOLOGY OF AGING (2014)
Parkinson disease and smoking revisited Ease of quitting is an early sign of the disease
Beate Ritz et al.
NEUROLOGY (2014)
Cortical spreading depression in traumatic brain injuries: Is there a role for astrocytes?
Daniel Torrente et al.
NEUROSCIENCE LETTERS (2014)
Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese
Jerome A. Roth
NEUROTOXICOLOGY (2014)
Motor impairment, depression, dementia: Which forms the impression of disease severity in Parkinson's disease?
Oliver Riedel et al.
PARKINSONISM & RELATED DISORDERS (2014)
Astrocytic modulation of blood brain barrier: perspectives on parkinson's disease
Ricardo Cabezas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Brain renin-angiotensin system and dopaminergic cell vulnerability
Jose L. Labandeira-Garcia et al.
FRONTIERS IN NEUROANATOMY (2014)
Cortical spreading depression and mitochondrial dysfunction with aging: lessons from ethanol abuse
George E. Barreto et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease
Altair Brito dos Santos et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Selective estrogen receptor modulators regulate reactive rnicroglia after penetrating brain injury
George E. Barreto et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
CYP2A6 Genotype but not Age Determines Cotinine Half-Life in Infants and Children
D. A. Dempsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells
Pablo Garrido-Gil et al.
EXPERIMENTAL NEUROLOGY (2013)
Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism
Manindra Nath Tiwari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Parkinson disease: from pathology to molecular disease mechanisms
David T. Dexter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse
Rita Perfeito et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease
Li Zuo et al.
GENE (2013)
Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations
Caijuan Shi et al.
JOURNAL OF MOLECULAR MODELING (2013)
Long-term nicotine treatment down-regulates α6β2*nicotinic receptor expression and function in nucleus accumbens
Xiomara A. Perez et al.
JOURNAL OF NEUROCHEMISTRY (2013)
3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats
Syuuichirou Suzuki et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
Adrien W. Schmid et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Pathophysiology of somatosensory abnormalities in Parkinson disease
Antonella Conte et al.
NATURE REVIEWS NEUROLOGY (2013)
Advances in the genetics of Parkinson disease
Joanne Trinh et al.
NATURE REVIEWS NEUROLOGY (2013)
Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
Paul Edison et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Diminished Activation of Motor Working-Memory Networks in Parkinson's Disease
Claudia Rottschy et al.
PLOS ONE (2013)
Cognitive impairments in Parkinson's disease
J. H. Liu et al.
AGING & MENTAL HEALTH (2012)
The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats
Alvin V. Terry et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Nicotine-Induced Morphological Changes in Rat Aorta: The Protective Role of Melatonin
Luigi Fabrizio Rodella et al.
CELLS TISSUES ORGANS (2012)
Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
Valentina Echeverria et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Smitha Pillai et al.
CURRENT DRUG TARGETS (2012)
Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status
Jaeseung Shin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Nicotine as a potential neuroprotective agent for Parkinson's disease
Maryka Quik et al.
MOVEMENT DISORDERS (2012)
Role for α6 nicotinic receptors in L-dopa-induced dyskinesias in parkinsonian mice
Maryka Quik et al.
NEUROPHARMACOLOGY (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
Mitochondrial functions in astrocytes: Neuroprotective implications from oxidative damage by rotenone
Ricardo Cabezas et al.
NEUROSCIENCE RESEARCH (2012)
A Systematic Review of Nicotine by Inhalation: Is There a Role for the Inhaled Route?
Brent Caldwell et al.
NICOTINE & TOBACCO RESEARCH (2012)
Cellular and molecular mechanisms of antioxidants in Parkinson's disease
Jhon Jairo Sutachan et al.
NUTRITIONAL NEUROSCIENCE (2012)
Effects of natural antioxidants in neurodegenerative disease
Sonia Luz Albarracin et al.
NUTRITIONAL NEUROSCIENCE (2012)
THE EFFECT OF NICOTINE ON ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN A MOUSE MODEL OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Stephen J. Davis et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Mitochondrial Biology and Parkinson's Disease
Celine Perier et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Importance of the Brain Angiotensin System in Parkinson's Disease
John W. Wright et al.
PARKINSONS DISEASE (2012)
Cotinine: beyond that expected, more than a biomarker of tobacco consumption
Valentina Echeverria Moran
FRONTIERS IN PHARMACOLOGY (2012)
Long-Term Nicotine Exposure Depresses Dopamine Release in Nonhuman Primate Nucleus Accumbens
Xiomara A. Perez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The cholinergic system and neostriatal memory functions
Robbert Havekes et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Targeting Nicotinic Receptors for Parkinson's Disease Therapy
Maryka Quik et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
Cotinine Reduces Amyloid-beta Aggregation and Improves Memory in Alzheimer's Disease Mice
Valentina Echeverria et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Stimulating Nicotinic Receptors Trigger Multiple Pathways Attenuating Cytotoxicity in Models of Alzheimer's and Parkinson's Diseases
Jun Kawamata et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Astrocytic-neuronal crosstalk: Implications for neuroprotection from brain injury
George E. Barreto et al.
NEUROSCIENCE RESEARCH (2011)
Racial Differences in the Relationship Between Number of Cigarettes Smoked and Nicotine and Carcinogen Exposure
Neal L. Benowitz et al.
NICOTINE & TOBACCO RESEARCH (2011)
WHAT GENETICS TELLS US ABOUT THE CAUSES AND MECHANISMS OF PARKINSON'S DISEASE
Olga Corti et al.
PHYSIOLOGICAL REVIEWS (2011)
α6β2*and α4β2*Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
Maryka Quik et al.
PHARMACOLOGICAL REVIEWS (2011)
Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
Mario Gustavo Murer et al.
FRONTIERS IN NEUROANATOMY (2011)
Can nicotine be used medicinally in Parkinson’s disease?
Claire Thiriez et al.
Expert Review of Clinical Pharmacology (2011)
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease
Hansruedi Bueeler
APOPTOSIS (2010)
Iron Leads to Memory Impairment that is Associated with a Decrease in Acetylcholinesterase Pathways
Vinicius Pieta Perez et al.
CURRENT NEUROVASCULAR RESEARCH (2010)
Acetylcholine-dopamine balance hypothesis in the striatum: An update
Toshihiko Aosaki et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Smoking duration, intensity, and risk of Parkinson disease
H. Chen et al.
NEUROLOGY (2010)
Mild cognitive impairment in Parkinson disease A multicenter pooled analysis
D. Aarsland et al.
NEUROLOGY (2010)
The amyloid-β25-35 injection into the CA1 region of the neonatal rat hippocampus impairs the long-term memory because of an increase of nitric oxide
Alfonso Diaz et al.
NEUROSCIENCE LETTERS (2010)
Smoking and Parkinson's Disease: Using Parental Smoking as a Proxy to Explore Causality
Eilis J. O'Reilly et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson Disease
Roy N. Alcalay et al.
ARCHIVES OF NEUROLOGY (2009)
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists
Jerry J. Buccafusco et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
Dong-Pyo Hong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
The Role of Catechols and Free Radicals in Benzene Toxicity: An Oxidative DNA Damage Pathway
George Barreto et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2009)
nAChRs Mediate Human Embryonic Stem Cell-Derived Endothelial Cells: Proliferation, Apoptosis, and Angiogenesis
Jin Yu et al.
PLOS ONE (2009)
Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders?
Pitchai Balakumar et al.
PHARMACOLOGICAL RESEARCH (2009)
Nonmotor Manifestations of Parkinson's Disease
Tanya Simuni et al.
ANNALS OF NEUROLOGY (2008)
Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells
Kunal Rehani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Striatal β-amyloid deposition in Parkinson disease with dementia
Michail E. Kalaitzakis et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Cotinine selectively activates a Subpopulation of α3/α6β2*nicotinic receptors in monkey striatum
Kathryn O'Leary et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model
Takashi Yanagida et al.
NEUROSCIENCE RESEARCH (2008)
Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol
Gloria E. Meredith et al.
PARKINSONISM & RELATED DISORDERS (2008)
Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors
Bruce E. McKay et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor α7 subunit gene knockout mice
Yoshihito X. Fujii et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone
George Barreto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Nicotine-mediated cell proliferation and angiogenesis - New twists to an old story
Piyali Dasgupta et al.
CELL CYCLE (2006)
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates
Maryka Quik et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Interaction between Aβ peptide and α synuclein:: Molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease
Pravat K. Mandal et al.
NEUROCHEMICAL RESEARCH (2006)
Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
M Quik et al.
JOURNAL OF NEUROSCIENCE (2006)
Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections
L Thompson et al.
JOURNAL OF NEUROSCIENCE (2005)
Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease
J De Reuck et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells
LC Gahring et al.
AAPS JOURNAL (2005)
Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model
R Kalra et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Inflammation and neurodegeneration in Parkinson's disease
PL McGeer et al.
PARKINSONISM & RELATED DISORDERS (2004)
Prevalence of Alzheimer lesions in Parkinson's disease
KA Jellinger
MOVEMENT DISORDERS (2003)
Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin
K Parain et al.
BRAIN RESEARCH (2003)
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
BA Faucheux et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients
L Burghaus et al.
PARKINSONISM & RELATED DISORDERS (2003)
The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
JJ Buccafusco et al.
LIFE SCIENCES (2003)
Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems
FM Zhou et al.
NEUROSCIENTIST (2003)
α-synuclein, Aβ and Alzheimer's disease
O Wirths et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Apoptosis in Parkinson's disease: Signals for neuronal degradation
WG Tatton et al.
ANNALS OF NEUROLOGY (2003)
Chronic self-administration of nicotine in rats impairs T cell responsiveness
R Kalra et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
MA Hernán et al.
ANNALS OF NEUROLOGY (2002)
Inflammation in neurodegenerative disease - A double-edged sword
T Wyss-Coray et al.
NEURON (2002)
Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking
NL Benowitz et al.
HYPERTENSION (2002)
Human Brain Nicotinic Receptors, their Distribution and Participation in Neuropsychiatric Disorders
A. J. Graham et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra
G Costa et al.
BRAIN RESEARCH (2001)
Pharmacokinetics of nicotine in healthy elderly people
L Molander et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
The nicotine inhaler - Clinical pharmacokinetics and comparison with other nicotine treatments
NG Schneider et al.
CLINICAL PHARMACOKINETICS (2001)
The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease:: studies with DMXBA (GTS-21)
WR Kem
BEHAVIOURAL BRAIN RESEARCH (2000)
A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease
TA Hughes et al.
NEUROLOGY (2000)
Nicotine metabolism and elimination kinetics in newborns
D Dempsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
